USE OF CYR61 IN THE TREATMENT AND DIAGNOSIS OF HUMAN UTERINE LEIOMYOMAS - Patent 1322778

(19)

(11)

EP 1 322 778 A2

(12)

(88)	Date of publication A3:
	03.10.2002

(43)	Date of publication:
	02.07.2003 Bulletin 2003/27

(21)	Application number: 01977351.4

(22)	Date of filing: 28.09.2001

(51)	International Patent Classification (IPC)⁷: C12P 19/34, A61K 38/00, A61K 48/00

(86)	International application number:
	PCT/US0130/783

(87)	International publication number:
	WO 0202/6193 (04.04.2002 Gazette 2002/12)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

29.09.2000 US 236887 P

(71)	Applicant: Wyeth
	Madison, New Jersey 07940 (US)

(72)	Inventors:
	ZHANG, Zhiming Malvern, PA 19010 (US) SAMPATH, Deepak Edgewater, NJ 07020 (US) ZHU, Yuan Ambler, PA 19002 (US) WINNEKER, Richard Penllyn, PA 19422 (US)

(74)	Representative: Ingham, Stephen H.
	Wyeth Pharmaceuticals,Patents & Trade Marks Dept.,Huntercombe Lane South,Taplow Maidenhead,Berks SL6 0PH Maidenhead,Berks SL6 0PH (GB)

(54)	USE OF CYR61 IN THE TREATMENT AND DIAGNOSIS OF HUMAN UTERINE LEIOMYOMAS